-

AHF Advocates to Keep Hammering Gilead CEO over Drug Profiteering

Protest Friday, June 16th will target drug company CEO at company’s Foster City HQ

SAN FRANCISCO--(BUSINESS WIRE)--On Friday, June 16th, advocates and mobilizers affiliated with AIDS Healthcare Foundation (AHF) will host a protest targeting HIV and Hepatitis C drug giant Gilead Sciences over the Bay Area company’s drug pricing and policies. The protest will take place in front of Gilead’s headquarters in Foster City, CA. The action is part of a yearlong aggressive advocacy campaign by AHF hammering Gilead and Daniel O’Day, its multimillionaire CEO, over his and the company’s drug profiteering.

WHAT:

 

Protest at Gilead Sciences HQ

 

 

 

WHEN:

 

Friday, June 16 - 12:00 p.m.

 

 

 

WHERE:

 

Gilead Sciences, Inc. Headquarters

 

 

333 Lakeside Dr., Foster City, CA 94404

 

 

 

WHO:

 

20 health advocates & mobilizers

AHF Onsite Foster City Media Contact: Jesse Brooks, +1.510.575.8245 cell jesse.brooks@ahf.org

According to CEO World Magazine, Daniel O’Day, Chairman and CEO of Gilead Sciences, was the 4th highest paid CEO in the healthcare industry in 2022 with total compensation of $21,621,253.

Advocates are protesting Gilead’s tone-deaf greed, particularly illegal restrictions the company placed early last year on access to 340B drug pricing for its branded hepatitis C treatments for certain pharmacies. Gilead now is one of more than 15 major drug companies that illegally have placed such restrictions on drugs.

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.7 million individuals in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region, and Eastern Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth, follow us @aidshealthcare or subscribe to our AHF podcast “AHFter Hours.”

Contacts

Ged Kenslea, AHF Senior Communications Director
323.791.5526
ged.kenslea@ahf.org

AIDS Healthcare Foundation


Release Summary
Advocates to Keep Hammering Gilead CEO over Drug Profiteering
Release Versions

Contacts

Ged Kenslea, AHF Senior Communications Director
323.791.5526
ged.kenslea@ahf.org

More News From AIDS Healthcare Foundation

Washington State Saves a Critical Health Care Safety Net, Says AHF

OLYMPIA, Wash.--(BUSINESS WIRE)--Washington State Saves a Critical Health Care Safety Net, Says AHF...

Governor Signs Emergency Legislation Restoring HIV Medication Access for More Than 12,000 Floridians

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Governor Ron DeSantis has signed into law emergency legislation restoring access to life-saving HIV medications for more than 12,000 Floridians who lost coverage when the Florida Department of Health cut the state’s AIDS Drug Assistance Program on March 1. The legislation, which passed both chambers of the Florida Legislature unanimously, appropriates $30.9 million in emergency bridge funding through June 30, 2026, restores Florida’s AIDS Drug Assistance...

AHF Urges EU to Stop Blocking Health Equity

BRUSSELS--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) Europe will hold an advocacy action in Brussels on March 18 at 11:00 a.m. CET on Archimedes Street, followed by an in-person and virtual press conference at Press Club Brussels Europe titled “EU: Stop Blocking Health Equity,” urging European Commission (EC) decision-makers to support a legally binding Pathogen Access and Benefit-Sharing (PABS) Annex to the WHO Pandemic Agreement. Click here to access the Press conference Zoom link, and...
Back to Newsroom